These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3388993)
21. [Parameters of connective tissue metabolism as markers in acute and chronic pancreatitis. A retrospective study with a cohort of normal subjects]. Löhr M; Spies B; Heptner G; Domschke S; Hahn EG Z Gastroenterol; 1991 May; 29(5):231-6. PubMed ID: 1950031 [TBL] [Abstract][Full Text] [Related]
22. Procollagen type-III aminoterminal peptide in serum and synovial fluid of dogs with hip dysplasia and coxarthrosis. Madsen JS; Jensen LT; Strøm H; Hørslev-Petersen K; Svalastoga E Am J Vet Res; 1990 Oct; 51(10):1544-6. PubMed ID: 2240774 [TBL] [Abstract][Full Text] [Related]
23. Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate. Biasi D; Bambara LM; Carletto A; Casaril M; Capra F; Caramaschi P; Corrocher R J Rheumatol; 1996 Mar; 23(3):453-4. PubMed ID: 8832981 [TBL] [Abstract][Full Text] [Related]
24. [Procollagen peptide in the serum of patients with rheumatoid arthritis and liver diseases]. Bentsen KD; Hørslev-Petersen K; Horn T; Junker P Ugeskr Laeger; 1986 Aug; 148(32):2011-4. PubMed ID: 3750528 [No Abstract] [Full Text] [Related]
25. Serum hyaluronan levels follow disease activity in vasculitis. West DC; Yaqoob M Clin Nephrol; 1997 Jul; 48(1):9-15. PubMed ID: 9247772 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of serum hyaluronic acid and type I and III procollagen propeptides in extrahepatic biliary atresia. Trivedi P; Dhawan A; Risteli J; Risteli L; Mirza M; Cheeseman P; Mowat AP Pediatr Res; 1995 Oct; 38(4):568-73. PubMed ID: 8559611 [TBL] [Abstract][Full Text] [Related]
27. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169 [TBL] [Abstract][Full Text] [Related]
28. Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine. Hørslev-Petersen K; Bentsen KD; Engström-Laurent A; Junker P; Halberg P; Lorenzen I Ann Rheum Dis; 1988 Feb; 47(2):116-26. PubMed ID: 3355249 [TBL] [Abstract][Full Text] [Related]
29. [Increased levels of circulating hyaluronate in the sera of patients with rheumatoid arthritis with special reference to joint destruction]. Yamada N; Uzuki M; Rikimaru A; Sakurai M; Sawai T Ryumachi; 1994 Aug; 34(4):752-60. PubMed ID: 7974026 [TBL] [Abstract][Full Text] [Related]
30. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919 [TBL] [Abstract][Full Text] [Related]
31. Limitation of portal vein embolization for extension of hepatectomy indication in patients with hepatocellular carcinoma. Hirohashi K; Tanaka H; Tsukamoto T; Kubo S; Shuto T; Takemura S; Yamamoto T; Kanazawa A; Ogawa M; Osugi H; Kinoshita H Hepatogastroenterology; 2004; 51(58):1084-7. PubMed ID: 15239251 [TBL] [Abstract][Full Text] [Related]
32. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636 [TBL] [Abstract][Full Text] [Related]
33. Interferon-alpha 2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection. Zöhrens G; Armbrust T; Meyer Zum Büschenfelde KH; Ramadori G Dig Dis Sci; 1994 Sep; 39(9):2007-13. PubMed ID: 8082511 [TBL] [Abstract][Full Text] [Related]
34. Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide. Rousseau JC; Sandell LJ; Delmas PD; Garnero P Methods Mol Med; 2004; 101():25-37. PubMed ID: 15299208 [TBL] [Abstract][Full Text] [Related]
35. Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. Rousseau JC; Zhu Y; Miossec P; Vignon E; Sandell LJ; Garnero P; Delmas PD Osteoarthritis Cartilage; 2004 Jun; 12(6):440-7. PubMed ID: 15135140 [TBL] [Abstract][Full Text] [Related]
36. Increased levels of type I and III collagen and hyaluronan in scleroderma skin. Søndergaard K; Heickendorff L; Risteli L; Risteli J; Zachariae H; Stengaard-Pedersen K; Deleuran B Br J Dermatol; 1997 Jan; 136(1):47-53. PubMed ID: 9039294 [TBL] [Abstract][Full Text] [Related]
37. [Diagnostic values of type III Procollagen N-terminal peptide and combination assay of type III procollagen N-terminal peptide with CEA and CA 19-9 in gastric cancer]. Akazawa S; Harada A; Futatsuki K Gan To Kagaku Ryoho; 1984 Jul; 11(7):1434-8. PubMed ID: 6588922 [TBL] [Abstract][Full Text] [Related]
38. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin. Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595 [TBL] [Abstract][Full Text] [Related]
39. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593 [TBL] [Abstract][Full Text] [Related]
40. [Prognostic value of serum markers for liver fibrosis in transient abnormal myelopoiesis (TAM)]. Kuroiwa Y; Suzuki N; Yamamoto M; Hatakeyama N; Hori T; Mizue N Rinsho Ketsueki; 2005 Nov; 46(11):1179-86. PubMed ID: 16440800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]